MARKET INTRODUCTION
Oseltamivir is an antiviral agent used to treat influenza A and influenza B. It is usually recommended that people at high risk of influenza avoid infection.
MARKET DYNAMICS
Market development is driven by factors such as increased awareness of influenza viruses and an increase in the number of government awareness initiatives. However, the side effects of the drug, including diarrhoea, vomiting, headache and dose change, hinder the expansion of the market. However, increased spending by government and healthcare firms on R&D programmes enhances industry growth opportunities.
MARKET SCOPE
The "Oseltamivir Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Oseltamivir Market with detailed market segmentation by formulation, indication, application. The Oseltamivir Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Oseltamivir Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Oseltamivir Market is segmented on the basis of formulation, indication, application. Based on type, the market is segmented as Capsule, Powder. Based on Indication, the market is segmented as Influenza A, Influenza B. Based on application, the market is segmented as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Oseltamivir Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Oseltamivir Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Oseltamivir Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Oseltamivir Market in these regions.
MARKET PLAYERS
The report covers key developments in the Oseltamivir Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Oseltamivir Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Oseltamivir Market in the global market. Below mentioned is the list of few companies engaged in the Oseltamivir Market.
The report also includes the profiles of key players in Oseltamivir Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Triveni Chemicals
- Cipla Inc
- Lotus International
- Shivam Pharma Export
- Cuidado Medico
- Nerium Pharmaceutical Export.
- Hetero Healthcare Ltd.
- Nagar Medicos
- Tissue Pharma
- MD Exports
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oseltamivir Market - By Fomulation
1.3.2 Oseltamivir Market - By Indication
1.3.3 Oseltamivir Market - By Application
1.3.4 Oseltamivir Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OSELTAMIVIR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OSELTAMIVIR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OSELTAMIVIR MARKET - GLOBAL MARKET ANALYSIS
6.1. OSELTAMIVIR - GLOBAL MARKET OVERVIEW
6.2. OSELTAMIVIR - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. OSELTAMIVIR MARKET - REVENUE AND FORECASTS TO 2027 - FOMULATION
7.1. OVERVIEW
7.2. FOMULATION MARKET FORECASTS AND ANALYSIS
7.3. CAPSULE
7.3.1. Overview
7.3.2. Capsule Market Forecast and Analysis
7.4. POWDER
7.4.1. Overview
7.4.2. Powder Market Forecast and Analysis
8. OSELTAMIVIR MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. INFLUENZA A
8.3.1. Overview
8.3.2. Influenza A Market Forecast and Analysis
8.4. INFLUENZA B
8.4.1. Overview
8.4.2. Influenza B Market Forecast and Analysis
9. OSELTAMIVIR MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. OSELTAMIVIR MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Oseltamivir Market Overview
10.1.2 North America Oseltamivir Market Forecasts and Analysis
10.1.3 North America Oseltamivir Market Forecasts and Analysis - By Fomulation
10.1.4 North America Oseltamivir Market Forecasts and Analysis - By Indication
10.1.5 North America Oseltamivir Market Forecasts and Analysis - By Application
10.1.6 North America Oseltamivir Market Forecasts and Analysis - By Countries
10.1.6.1 United States Oseltamivir Market
10.1.6.1.1 United States Oseltamivir Market by Fomulation
10.1.6.1.2 United States Oseltamivir Market by Indication
10.1.6.1.3 United States Oseltamivir Market by Application
10.1.6.2 Canada Oseltamivir Market
10.1.6.2.1 Canada Oseltamivir Market by Fomulation
10.1.6.2.2 Canada Oseltamivir Market by Indication
10.1.6.2.3 Canada Oseltamivir Market by Application
10.1.6.3 Mexico Oseltamivir Market
10.1.6.3.1 Mexico Oseltamivir Market by Fomulation
10.1.6.3.2 Mexico Oseltamivir Market by Indication
10.1.6.3.3 Mexico Oseltamivir Market by Application
10.2. EUROPE
10.2.1 Europe Oseltamivir Market Overview
10.2.2 Europe Oseltamivir Market Forecasts and Analysis
10.2.3 Europe Oseltamivir Market Forecasts and Analysis - By Fomulation
10.2.4 Europe Oseltamivir Market Forecasts and Analysis - By Indication
10.2.5 Europe Oseltamivir Market Forecasts and Analysis - By Application
10.2.6 Europe Oseltamivir Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Oseltamivir Market
10.2.6.1.1 Germany Oseltamivir Market by Fomulation
10.2.6.1.2 Germany Oseltamivir Market by Indication
10.2.6.1.3 Germany Oseltamivir Market by Application
10.2.6.2 France Oseltamivir Market
10.2.6.2.1 France Oseltamivir Market by Fomulation
10.2.6.2.2 France Oseltamivir Market by Indication
10.2.6.2.3 France Oseltamivir Market by Application
10.2.6.3 Italy Oseltamivir Market
10.2.6.3.1 Italy Oseltamivir Market by Fomulation
10.2.6.3.2 Italy Oseltamivir Market by Indication
10.2.6.3.3 Italy Oseltamivir Market by Application
10.2.6.4 Spain Oseltamivir Market
10.2.6.4.1 Spain Oseltamivir Market by Fomulation
10.2.6.4.2 Spain Oseltamivir Market by Indication
10.2.6.4.3 Spain Oseltamivir Market by Application
10.2.6.5 United Kingdom Oseltamivir Market
10.2.6.5.1 United Kingdom Oseltamivir Market by Fomulation
10.2.6.5.2 United Kingdom Oseltamivir Market by Indication
10.2.6.5.3 United Kingdom Oseltamivir Market by Application
10.2.6.6 Rest of Europe Oseltamivir Market
10.2.6.6.1 Rest of Europe Oseltamivir Market by Fomulation
10.2.6.6.2 Rest of Europe Oseltamivir Market by Indication
10.2.6.6.3 Rest of Europe Oseltamivir Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Oseltamivir Market Overview
10.3.2 Asia-Pacific Oseltamivir Market Forecasts and Analysis
10.3.3 Asia-Pacific Oseltamivir Market Forecasts and Analysis - By Fomulation
10.3.4 Asia-Pacific Oseltamivir Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Oseltamivir Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Oseltamivir Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Oseltamivir Market
10.3.6.1.1 Australia Oseltamivir Market by Fomulation
10.3.6.1.2 Australia Oseltamivir Market by Indication
10.3.6.1.3 Australia Oseltamivir Market by Application
10.3.6.2 China Oseltamivir Market
10.3.6.2.1 China Oseltamivir Market by Fomulation
10.3.6.2.2 China Oseltamivir Market by Indication
10.3.6.2.3 China Oseltamivir Market by Application
10.3.6.3 India Oseltamivir Market
10.3.6.3.1 India Oseltamivir Market by Fomulation
10.3.6.3.2 India Oseltamivir Market by Indication
10.3.6.3.3 India Oseltamivir Market by Application
10.3.6.4 Japan Oseltamivir Market
10.3.6.4.1 Japan Oseltamivir Market by Fomulation
10.3.6.4.2 Japan Oseltamivir Market by Indication
10.3.6.4.3 Japan Oseltamivir Market by Application
10.3.6.5 South Korea Oseltamivir Market
10.3.6.5.1 South Korea Oseltamivir Market by Fomulation
10.3.6.5.2 South Korea Oseltamivir Market by Indication
10.3.6.5.3 South Korea Oseltamivir Market by Application
10.3.6.6 Rest of Asia-Pacific Oseltamivir Market
10.3.6.6.1 Rest of Asia-Pacific Oseltamivir Market by Fomulation
10.3.6.6.2 Rest of Asia-Pacific Oseltamivir Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Oseltamivir Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Oseltamivir Market Overview
10.4.2 Middle East and Africa Oseltamivir Market Forecasts and Analysis
10.4.3 Middle East and Africa Oseltamivir Market Forecasts and Analysis - By Fomulation
10.4.4 Middle East and Africa Oseltamivir Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Oseltamivir Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Oseltamivir Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Oseltamivir Market
10.4.6.1.1 South Africa Oseltamivir Market by Fomulation
10.4.6.1.2 South Africa Oseltamivir Market by Indication
10.4.6.1.3 South Africa Oseltamivir Market by Application
10.4.6.2 Saudi Arabia Oseltamivir Market
10.4.6.2.1 Saudi Arabia Oseltamivir Market by Fomulation
10.4.6.2.2 Saudi Arabia Oseltamivir Market by Indication
10.4.6.2.3 Saudi Arabia Oseltamivir Market by Application
10.4.6.3 U.A.E Oseltamivir Market
10.4.6.3.1 U.A.E Oseltamivir Market by Fomulation
10.4.6.3.2 U.A.E Oseltamivir Market by Indication
10.4.6.3.3 U.A.E Oseltamivir Market by Application
10.4.6.4 Rest of Middle East and Africa Oseltamivir Market
10.4.6.4.1 Rest of Middle East and Africa Oseltamivir Market by Fomulation
10.4.6.4.2 Rest of Middle East and Africa Oseltamivir Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Oseltamivir Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Oseltamivir Market Overview
10.5.2 South and Central America Oseltamivir Market Forecasts and Analysis
10.5.3 South and Central America Oseltamivir Market Forecasts and Analysis - By Fomulation
10.5.4 South and Central America Oseltamivir Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Oseltamivir Market Forecasts and Analysis - By Application
10.5.6 South and Central America Oseltamivir Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Oseltamivir Market
10.5.6.1.1 Brazil Oseltamivir Market by Fomulation
10.5.6.1.2 Brazil Oseltamivir Market by Indication
10.5.6.1.3 Brazil Oseltamivir Market by Application
10.5.6.2 Argentina Oseltamivir Market
10.5.6.2.1 Argentina Oseltamivir Market by Fomulation
10.5.6.2.2 Argentina Oseltamivir Market by Indication
10.5.6.2.3 Argentina Oseltamivir Market by Application
10.5.6.3 Rest of South and Central America Oseltamivir Market
10.5.6.3.1 Rest of South and Central America Oseltamivir Market by Fomulation
10.5.6.3.2 Rest of South and Central America Oseltamivir Market by Indication
10.5.6.3.3 Rest of South and Central America Oseltamivir Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL OSELTAMIVIR MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. OSELTAMIVIR MARKET, KEY COMPANY PROFILES
13.1. TRIVENI CHEMICALS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CIPLA INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. LOTUS INTERNATIONAL
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SHIVAM PHARMA EXPORT
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CUIDADO MEDICO
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NERIUM PHARMACEUTICAL EXPORT.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. HETERO HEALTHCARE LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NAGAR MEDICOS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. TISSUE PHARMA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MD EXPORTS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Triveni Chemicals
2. Cipla Inc
3. Lotus International
4. Shivam Pharma Export
5. Cuidado Medico
6. Nerium Pharmaceutical Export.
7. Hetero Healthcare Ltd.
8. Nagar Medicos
9. Tissue Pharma
10. MD Exports